A carregar...
Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?: Expert Opinion on Biological Therapy
INTRODUCTION: Monoclonal antibodies (mAbs) targeting checkpoint inhibitors have demonstrated clinical benefit in treating patients with cancer and have paved the way for additional immune-modulating mAbs such as those targeting costimulatory receptors. The full clinical utility of these agents, howe...
Na minha lista:
| Publicado no: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4955764/ https://ncbi.nlm.nih.gov/pubmed/26855028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2016.1152256 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|